Collectively, these previous discoveries suggested the role of PROX1 in metabolic reprogramming in cancer, but this hypothesis has not been conclusively demonstrated, and sufficient data are lacking on the specific role of PROX1 in CRC cell glucose metabolism. This evidence concerns the gene PROX1 and colorectal carcinoma.